세계의 산후 우울증 치료 시장 보고서(2025년)
Postpartum Depression Treatment Global Market Report 2025
상품코드 : 1751078
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

산후 우울증 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 연평균 7.4%의 CAGR로 17억 달러 규모에 이를 것으로 예상됩니다. 예측 기간 동안의 성장은 새로운 속효성 치료법 개발, 디지털 정신건강 솔루션의 채택 확대, 정신건강 서비스에 대한 보험 적용 확대, 개별화된 치료 접근법에 대한 수요 증가, 호르몬 요법에 대한 관심 증가 등에 기인할 것으로 보입니다. 예측 기간 동안 예상되는 주요 동향으로는 신경 스테로이드 기반 치료의 등장, 산후 관리에서 원격의료의 사용 증가, 정신건강 진단에 AI의 통합, 영양 보충제와 식이 중재의 역할 증가, 고용주가 후원하는 정신건강 프로그램의 확대 등이 있습니다.

임신 중 정신건강 문제에 대한 인식이 높아짐에 따라 산후 우울증 치료 시장의 성장이 촉진될 것으로 예상됩니다. 임신 중 정신건강 문제에는 임산부에게 영향을 미치는 다양한 정서적, 심리적, 정신적 상태가 포함됩니다. 이러한 문제는 종종 스트레스와 호르몬 변화로 인해 증가하여 정서적 취약성을 증가시키고 여성이 임신 중 신체적, 사회적, 심리적 요구를 관리하기가 더 어려워집니다. 산후 우울증 치료는 슬픔, 불안, 피로 등의 증상을 완화하고, 정서적 회복력을 높이고, 건강한 모성애를 형성하는 데 도움이 될 수 있습니다. 예를 들어, 2024년 10월, 미국을 기반으로 임산부의 정신건강 개선을 위해 노력하는 비영리 단체인 MMHLA(Maternal Mental Health Leadership Alliance)는 임산부의 정신건강 상태가 가장 흔한 임신 합병증이며, 미국에서는 연간 80 만 가정이 영향을 받는다고 보고했습니다. 놀랍게도 이러한 사례의 75%가 치료되지 않아 산모, 아기, 가족에게 장기적인 위험을 초래하고 있습니다. 이러한 인식의 증가는 산후 우울증 치료 시장의 주요 촉진요인으로 작용하고 있습니다.

산후 우울증 치료 시장의 기업들은 특히 처방전 디지털 산후 우울증 치료 등 여러 치료법의 통합을 통해 진단과 치료에 큰 진전을 이루고 있습니다. 처방전 디지털 치료제(DTx)는 산후 우울증(PPD)의 관리 및 치료를 위해 의료진이 처방하는 임상적으로 검증된 모바일 기반 치료제입니다. 예를 들어, 2024년 4월 미국 디지털 헬스 기업 큐리오 디지털 치료제(Curio Digital Therapeutics)는 산후 우울증에 대한 최초의 처방전 디지털 치료제인 맘리프트 플러스(Mom Lift Plus)의 FDA 승인을 발표하였습니다. 이 8주간의 프로그램에서는 의료진의 모니터링 하에 인지행동치료(CBT), 행동활성화치료(BAT), 대인관계치료(IPT), 변증법적 행동치료(DBT)가 모바일 기기를 통해 이루어집니다. 중요한 연구 결과에 따르면, 엄마리프트 플러스 사용자의 에든버러 산후 우울증 척도(EPDS) 점수가 대조군에 비해 임상적으로 유의미하게 개선된 것으로 나타났습니다. 이번 FDA 승인으로 경증에서 중등도의 PPD를 치료할 수 있는 비약물적 대안이 여성들에게 보다 친숙하게 다가갈 수 있게 됐습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Postpartum depression (PPD) treatment refers to the medical and psychological care provided to individuals experiencing depression after childbirth. It typically involves a combination of therapy, medication, and support strategies aimed at alleviating symptoms such as persistent sadness, anxiety, fatigue, and difficulty bonding with the baby. Treatment options include medications, psychotherapy, hormonal therapy, and lifestyle interventions designed to improve maternal mental health and overall well-being.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of postpartum depression treatment include postpartum anxiety, postpartum blues, postpartum post-traumatic stress disorder (PTSD), postpartum obsessive-compulsive disorder (OCD), postpartum panic disorder, and postpartum psychosis. Postpartum anxiety is a condition in which new mothers experience excessive worry, fear, or nervousness after childbirth. Treatment options such as antidepressants, hormone therapy, psychotherapy, and other interventions are available for various demographics, including adolescents and adults. These treatments are distributed through various sales channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The postpartum depression treatment market research report is one of a series of new reports from The Business Research Company that provides postpartum depression treatment market statistics, including postpartum depression treatment industry global market size, regional shares, competitors with a postpartum depression treatment market share, detailed postpartum depression treatment market segments, market trends and opportunities, and any further data you may need to thrive in the postpartum depression treatment industry. This postpartum depression treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The postpartum depression treatment market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to increasing awareness of maternal mental health, the growing prevalence of postpartum depression, advancements in antidepressant medications, rising acceptance of psychotherapy, and government initiatives supporting maternal mental health.

The postpartum depression treatment market size is expected to see strong growth in the next few years. It will grow to $1.70 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth during the forecast period can be attributed to the development of novel fast-acting treatments, the increasing adoption of digital mental health solutions, expanding insurance coverage for mental health services, rising demand for personalized treatment approaches, and a growing focus on hormonal therapies. Key trends expected in the forecast period include the emergence of neurosteroid-based therapies, the increasing use of telemedicine for postpartum care, the integration of AI in mental health diagnostics, the growing role of nutraceuticals and dietary interventions, and the expansion of employer-sponsored mental health programs.

The growing awareness of mental health issues during pregnancy is expected to drive the growth of the postpartum depression treatment market. Mental health issues during pregnancy encompass a range of emotional, psychological, and psychiatric conditions that affect women while they are pregnant. These issues are often heightened due to stress and hormonal changes, which can increase emotional vulnerability and make it more challenging for women to manage the physical, social, and psychological demands of pregnancy. Postpartum depression treatment helps alleviate symptoms such as sadness, anxiety, and fatigue, enhancing emotional resilience and fostering healthier mother-child bonding. For example, in October 2024, the Maternal Mental Health Leadership Alliance (MMHLA), a US-based nonprofit dedicated to improving maternal mental health, reported that maternal mental health conditions are the most common pregnancy complication, affecting 800,000 U.S. families annually. Alarmingly, 75% of these cases go untreated, posing long-term risks to mothers, babies, and families. This growing awareness is a major driver of the postpartum depression treatment market.

Companies in the postpartum depression treatment market are making significant advancements in diagnosis and treatment, particularly through the integration of multiple therapeutic modalities, such as prescription digital postpartum depression treatments. Prescription digital therapeutics (DTx) are clinically validated, mobile-based treatments that healthcare providers prescribe to manage and treat postpartum depression (PPD). For example, in April 2024, Curio Digital Therapeutics Inc., a US-based digital health company, announced FDA clearance for MamaLift Plus, the first prescription digital therapeutic for postpartum depression. This eight-week program delivers cognitive behavioral therapy (CBT), behavioral activation therapy (BAT), interpersonal therapy (IPT), and dialectical behavior therapy (DBT) via mobile devices under healthcare provider supervision. A pivotal study showed significantly higher rates of clinically meaningful improvement in Edinburgh Postnatal Depression Scale (EPDS) scores for MamaLift Plus users compared to a control group. This FDA clearance offers women a non-pharmaceutical option for treating mild to moderate PPD, making it more accessible.

In December 2022, Biogen Inc., a US-based company focusing on neurology therapies, partnered with Sage Therapeutics Inc. to develop treatments for major depressive disorder (MDD) and postpartum depression (PPD). This collaboration allows the companies to work together on medications for PPD, MDD, various mental health conditions, and neurological disorders such as essential tremors. Sage Therapeutics is a US-based company specializing in treatments for neurological conditions, including postpartum depression.

Major players in the postpartum depression treatment market are Biogen Inc., Inspira Health Network, LifeStance Health Inc., Max Healthcare Institute Limited, American Well Corporation, Sakra Premium Hospital Private Limited, Talkspace Inc., Mental Health America, 7 Cups Inc., Marinus Pharmaceuticals Inc., Brii Biosciences Limited, Beyond Blue Ltd, Blooming Wellness Center, Sage Therapeutics Inc., NURX Inc., Curio Digital Therapeutics Inc., Genesis Lifestyle Medicine, Postpartum Society of Florida, TalktoAngel, The Motherhood Center.

North America was the largest region in the postpartum depression treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in postpartum depression treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the postpartum depression treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The postpartum depression treatment market consists of revenues earned by entities by providing services such as psychotherapy, medication management, counseling, digital mental health solutions, and alternative therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The postpartum depression treatment market also includes sales of antidepressant medications, hormone-based therapies, digital health platforms, telehealth services, wearable devices, and mobile applications that support mental health management. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Postpartum Depression Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postpartum depression treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for postpartum depression treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postpartum depression treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Postpartum Depression Treatment Market Characteristics

3. Postpartum Depression Treatment Market Trends And Strategies

4. Postpartum Depression Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Postpartum Depression Treatment Growth Analysis And Strategic Analysis Framework

6. Postpartum Depression Treatment Market Segmentation

7. Postpartum Depression Treatment Market Regional And Country Analysis

8. Asia-Pacific Postpartum Depression Treatment Market

9. China Postpartum Depression Treatment Market

10. India Postpartum Depression Treatment Market

11. Japan Postpartum Depression Treatment Market

12. Australia Postpartum Depression Treatment Market

13. Indonesia Postpartum Depression Treatment Market

14. South Korea Postpartum Depression Treatment Market

15. Western Europe Postpartum Depression Treatment Market

16. UK Postpartum Depression Treatment Market

17. Germany Postpartum Depression Treatment Market

18. France Postpartum Depression Treatment Market

19. Italy Postpartum Depression Treatment Market

20. Spain Postpartum Depression Treatment Market

21. Eastern Europe Postpartum Depression Treatment Market

22. Russia Postpartum Depression Treatment Market

23. North America Postpartum Depression Treatment Market

24. USA Postpartum Depression Treatment Market

25. Canada Postpartum Depression Treatment Market

26. South America Postpartum Depression Treatment Market

27. Brazil Postpartum Depression Treatment Market

28. Middle East Postpartum Depression Treatment Market

29. Africa Postpartum Depression Treatment Market

30. Postpartum Depression Treatment Market Competitive Landscape And Company Profiles

31. Postpartum Depression Treatment Market Other Major And Innovative Companies

32. Global Postpartum Depression Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Postpartum Depression Treatment Market

34. Recent Developments In The Postpartum Depression Treatment Market

35. Postpartum Depression Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기